氮卓斯汀

氮卓斯汀

1

氮卓斯汀喷雾剂和内舒拿在研究中均耐受良好。

Both ASTELIN and Nasonex were well tolerated in the study .
2

氮卓斯汀喷雾剂在8小时变应原暴露期间任一时间点与安慰剂组比较持续减轻症状，有显著差异性。

This significant difference in symptom reduction for ASTELIN persisted at each time point during the8-hour allergen exposure ersus placebo .
3

因为氮卓斯汀喷雾剂是一种高竞争性治疗类别产物，因此快速缓解非常重要，已建立的快速显效是氮卓斯汀喷雾剂潜在市场领导者地位的标志。

Because ASTELIN is a product in a highly competitive therapeutic category where fast relief is important , an established rapid onset of action gives ASTELIN the hallmark of a potential market leader .